Page last updated: 2024-12-07

o-methylserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

o-Methylserine is a non-proteinogenic amino acid that has been studied for its potential therapeutic properties. It has been shown to inhibit the activity of serine racemase, an enzyme involved in the synthesis of D-serine, a neurotransmitter implicated in learning and memory. o-Methylserine is also a potent inhibitor of the enzyme serine hydroxymethyltransferase, which is involved in the biosynthesis of glycine. These findings suggest that o-Methylserine could be a potential therapeutic agent for neurological disorders. There are various synthetic methods for o-Methylserine. One method involves the alkylation of serine with methyl iodide in the presence of a base. Another method involves the condensation of formaldehyde with glycine in the presence of a catalyst. o-Methylserine has been shown to be effective in treating a variety of neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. o-Methylserine is a promising drug candidate for the treatment of neurological disorders, and further research is ongoing to explore its therapeutic potential.'

O-methylserine: RN given refers to compound with no isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O-methylserine : A serine derivative that is L-serine with a methyl group replacing the hydrogen on the hydroxy side chain. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID88250
CHEMBL ID4085261
CHEBI ID74798
SCHEMBL ID127190
MeSH IDM0252523

Synonyms (34)

Synonym
AC-1107
o-methylserine
4219-94-7
nsc-62335
32620-11-4
3-methoxyalanine
serine, o-methyl-
o-methyl-l-serine
(2s)-2-amino-3-methoxypropanoic acid
(s)-2-amino-3-methoxypropanoic acid
dl-serine, o-methyl-
r5mjk98ykk ,
o-methyl-l-ser
CHEBI:74798
nsc 62335
BP-11131
SCHEMBL127190
AM808146
(2s)-2-amino-3-methoxy-propanoic acid
l-serine, o-methyl-
alanine, 3-methoxy-, dl-
J-507795
CS-W006151
(s)-2-amino-3-methoxy-propionic acid (h-l-ser(me)-oh)
mfcd00145257
DS-5174
Q27144909
DTXSID60941607
h-ser(me)-oh
o-methyl-serine
CHEMBL4085261
AKOS016843672
F10843
EN300-191527
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
L-serine derivativeA proteinogenic amino acid derivative resulting from reaction of L-serine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-serine by a heteroatom.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]